Public Health England set to be replaced by a new agency to specifically deal with pandemics
August 17, 2020Sales and Marketing COVID, Public Health England, pandemic, phe
Public Health England is set to be replaced with a new agency to prepare the country to deal with future …
Amazon Pharmacy launches in India
August 17, 2020Sales and Marketing India, amazon, pharma
Amazon has entered the pharmaceutical market by launching ‘Amazon Pharmacy’ in India.
Sanofi to buy Principia Biopharma for $3.4 billion
August 17, 2020Sales and Marketing MS, Sanofi
Sanofi is set to buy California based Principia Biopharma in a deal that is worth $3.4 billion. This deal means …
FDA approves Roche’s Enspryng for neuromyelitis optica
August 17, 2020Sales and Marketing COVID, COVID-19, coronavirus
The FDA has granted approval for Roche’s Enspryng for treating the central nervous system disorder neuromyelitis optica. The drug (satralizumab) …
FDA panel votes 9-1 in favour of approval for Mesoblast’s Ryoncil in paediatric steroid-refractory acute graft versus host disease
August 14, 2020Medical Communications, Sales and Marketing FDA, Mesoblast, Ryoncil, pharma
It’s good news for Mesoblast as an expert FDA panel gave a glowing recommendation for the approval in the US …
Philippines expected to approve Russia’s ‘Sputnik’ COVID-19 vaccine
August 14, 2020Medical Communications COVID, COVID-19, coronavirus, vaccines
The Philippines is expected to begin large scale human testing of Russia’s controversial ‘Sputnik’ coronavirus vaccine. Rodrigo Duterte, the President …
Novavax and Janssen commit 90 million COVID-19 vaccine doses to UK Government with two new deals
August 14, 2020Manufacturing and Production, Medical Communications, Sales and Marketing COVID-19, J&J, JJ, Novavax, UK, pharma
The UK Government has signed a new deal with Johnson & Johnson and Novavax to secure 90 million orders of …
Top Russian doctor quits over questionable ethics that rushed through coronavirus vaccine approval
August 14, 2020Medical Communications
Professor Alexander Chuchalin has quit the Russian Health Ministry’s ethics council due to the quick approval process for the country’s …
Top Ten most popular articles on Pharmafile.com this week
August 14, 2020Medical Communications COVID-19, coronavirus, pandemic
The top 10 news stories this week once again focus on coronavirus treatments and vaccines, as President Putin announced that …
Gilead’s Truvada becomes first China-approved drug to prevent HIV-1
August 13, 2020Sales and Marketing China, Truvada, approval. HIV
China’s National Medical Products Administration (NMPA) has awarded approval to Gilead’s Truvada in a pre-exposure prophylaxis (PrEP) indication to prevent …
MHRA designates cenobamate as a Promising Innovative Medicine for treating drug resistant seizures
August 13, 2020Research and Development MHRA, cenobamate, seizures
Arvelle Therapeutics has announced that the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) has given their anti-seizure medication (cenobamate) …
COVID-19 patients are experiencing long-term effects from the virus
August 13, 2020COVID, COVID-19, coronavirus
Almost a third of doctors have treated patients for long-term symptoms caused by coronavirus, according to a new study.
FDA approves NS Pharma’s Viltepso for Duchenne muscular dystrophy, but concerns over benefit persist
August 13, 2020Sales and Marketing Duchenne Muscular Dystrophy, FDA, NS pharma, Viltepso
NS Pharma has claimed a tentative FDA approval for its Viltepso (viltolarsen) injection in the treatment of Duchenne muscular dystrophy …
Coronavirus fake news has led to hundreds of deaths, according to a new study
August 13, 2020Medical Communications COVID, coronavirus, fake news
At least 800 people have died around the world from COVID-19 misinformation in the first three months of 2020, according …
Racial minority groups are not adequately represented in COVID-19 clinical studies, research argues
August 12, 2020Research and Development COVID-19, Gilead, pharma, remdesivir
New research has warned that minority groups and people of colour are underrepresented in current trials for COVID-19 therapies, despite …
Bristol Myers Squibb announces positive results from Opdivo clinical trials
August 12, 2020Research and Development Bristol-Myers Squibb, Cancer, bristol myers squibb
Bristol Myers Squibb has announced positive data from two Phase 3 clinical trials of its drug Opdivo. The first trial …
Mexico to hold trials for Chinese and American COVID-19 vaccines
August 12, 2020Research and Development COVID-19, Mexico, Mexico coronavirus
Mexico aims to conduct late stage trials for coronavirus vaccines designed by US and Chinese companies. This is in hope …
Moderna commits 100 million COVID-19 vaccine doses to the US
August 12, 2020Manufacturing and Production, Research and Development, Sales and Marketing COVID-19, Moderna, US, Vaccine, pharma
Moderna continues to rise to meet the demands of the pandemic, signing a new deal with the US Government to …
Pharmafile.com’s weekly COVID-19 news round-up
August 12, 2020Research and Development COVID-19, coronavirus, covid news
The coronavirus news this week once again focuses on vaccines, as AstraZeneca signed its first deal in China to produce …
Bayer scoops up women’s healthcare biotech KaNDy Therapeutics in potential $1bn+ deal
August 11, 2020Manufacturing and Production, Research and Development, Sales and Marketing Bayer, KaNDy Therapeutics, menopause, pharma
Bayer is set to acquire UK-based biotech KaNDy Therapeutics, assimilating the firm’s women’s healthcare development portfolio in a newly announced …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
